Keefe Bruyette raises Allstate stock EPS estimates on auto growth By Investing.com

Allstate recorded $140M of catastrophe losses in February ($111M after-tax) and $315M for Jan-Feb, while auto policies in force rose 3.0% y/y and 2025 revenue increased 5.6% to $67.7B. Keefe, Bruyette & Woods reiterated an Outperform, raised 2026 EPS to $26.60 and 2027 to $26.80, cut its Q1-2026 catastrophe estimate to $1.052B and set a $260 price target (9.7x 2027 EPS). Contrast: Goldman Sachs downgraded the stock to Neutral and cut its target to $231, while Raymond James kept a Strong Buy with a $260 target; InvestingPro notes a P/E of 5.37 and that the stock appears undervalued. Analysts have made six upward earnings revisions for the upcoming period.

Analysis

Recent underwriting momentum in personal auto is more meaningful than it appears: rising policies-in-force ahead of meaningful rate resets implies retention-driven volume rather than rate-driven top-line, which should raise near-term earned premium growth without immediate margin dilution. That dynamic tends to translate into positive reserve development probability (through earned premium leverage) over the next 3–12 months, but it also opens the door to competitive repricing mid-cycle as carriers chase share.

Lower-than-expected catastrophe outturns create a two-way market impact: primary carriers see immediate underwriting lift and lower ceded spend while reinsurers face premium pressure and margin compression into the next renewals season. Expect a lagged adjustment — primary insurers will book benefits quickly, but reinsurers and capital-market retrocession structures will only repriced over 6–18 months, creating a window where primary insurers can compound outperformance.

Key risks are insurer-specific reserve redevelopment and concentration in high-volatility geographies where political or regulatory intervention (rate caps, AOB rules) can reverse profitability quickly. A single large event or adverse reserve emergence can wipe out several quarters of underwriting gains; conversely, sustained benign catastrophe frequency plus stable investment income could re-rate cheap, well-capitalized insurers over 3–12 months. Monitor state-level filings, Q1 reserve releases, and reinsurer renewal terms as the primary near-term catalysts.

Key Decisions for Investors

• Long ALL (12-month horizon): buy a moderately bullish call spread (near-the-money buy / one higher strike sell) to capture a 20–40% upside re-rate if underwriting momentum and reserve releases persist; cost defined, max loss = premium paid, target return 2.5–4x premium. Entry on consolidation or <5% pullback to current levels.
• Pair trade (6–12 months): long ALL / short PGR (equal dollar exposure) to express differential execution on auto policy growth and expense leverage — set stop-loss at 8% on either leg and take-profit if spread narrows by 50% or ALL outperforms PGR by 20%. Expect asymmetric payoff if primary-insurer tailwinds persist.
• Reduce/avoid direct reinsurer exposure (3–9 months): favor underweight or short selective reinsurer names into renewals season where pricing is likely to soften; target 10–20% downside vs market if retrocession capacity expands and rate-on-line falls. Use single-name puts or inverse ETFs for tactical sizing.
• Event alerts & risk control: set alerts for (a) Q1 reserve development announcements, (b) state regulatory actions in top growth states, and (c) reinsurance renewal pricing headlines — tighten position sizing to 50% if any two events indicate adverse reserve or regulatory risk within 30 days.